153 related articles for article (PubMed ID: 32755442)
1. Nonkeratinizing Nasopharyngeal Carcinoma, Undifferentiated Type With Trisomy 2: A Case Report and Short Review of Cytogenetic and Molecular Literature.
Pontoriero F; Silverman AM; Pascasio JM; Bajaj R
Pediatr Dev Pathol; 2020; 23(6):448-452. PubMed ID: 32755442
[TBL] [Abstract][Full Text] [Related]
2. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population.
Svajdler M; Kaspirkova J; Mezencev R; Laco J; Torday T; Dubinsky P; Straka L; Ondic O; Michal M; Skalova A
Neoplasma; 2016; 63(1):107-14. PubMed ID: 26639240
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr Virus in Nasopharyngeal Carcinoma of Guatemalan and Brazilian Patients.
Rumayor Piña A; Dos Santos HT; Carlos R; Altemani A; de Almeida OP
Int J Surg Pathol; 2017 Jun; 25(4):304-309. PubMed ID: 27881609
[TBL] [Abstract][Full Text] [Related]
4. Viral markers in nasopharyngeal carcinoma: A systematic review and meta-analysis on the detection of p16
Tham T; Machado R; Russo DP; Herman SW; Teegala S; Costantino P
Am J Otolaryngol; 2021; 42(1):102762. PubMed ID: 33202328
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country.
Simon J; Schroeder L; Ingarfield K; Diehl S; Werner J; Brenner N; Liu Z; Pawlita M; Pring M; Butt J; Ness A; Waterboer T
Int J Cancer; 2020 Jul; 147(2):461-471. PubMed ID: 32279316
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland.
Ruuskanen M; Irjala H; Minn H; Vahlberg T; Randen-Brady R; Hagström J; Syrjänen S; Leivo I
Head Neck; 2019 Feb; 41(2):349-357. PubMed ID: 30549170
[TBL] [Abstract][Full Text] [Related]
7. Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
Feng G; Xu Y; Ma N; Midorikawa K; Oikawa S; Kobayashi H; Nakamura S; Ishinaga H; Zhang Z; Huang G; Takeuchi K; Murata M
BMC Cancer; 2021 Aug; 21(1):929. PubMed ID: 34407796
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostics of nasopharyngeal carcinoma with Epstein-Barr virus (Herpesviridae, Lymphocryptovirus, HHV-4) serological and molecular markers in cases of undetected primary tumor location.].
Senyuta NB; Smirnova KV; Kondratova VN; Ignatova AV; Mudunov AM; Dushenkina TE; Liechtenstein AV; Gurtsevich VE
Vopr Virusol; 2019; 64(5):229-237. PubMed ID: 32167688
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptor 2 is highly sensitive and specific for Epstein-Barr virus-associated nasopharyngeal carcinoma.
Viswanathan K; Sadow PM
Hum Pathol; 2021 Nov; 117():88-100. PubMed ID: 34416258
[TBL] [Abstract][Full Text] [Related]
10. Nasopharyngeal carcinoma: the role of the Epstein-Barr virus.
Chu EA; Wu JM; Tunkel DE; Ishman SL
Medscape J Med; 2008 Jul; 10(7):165. PubMed ID: 18769688
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in NKG2D axis and susceptibility to Epstein-Barr virus-induced nasopharyngeal carcinoma.
Viet NH; Trung NQ; Dong LT; Trung LQ; Espinoza JL
J Cancer Res Clin Oncol; 2021 Mar; 147(3):713-723. PubMed ID: 33392659
[TBL] [Abstract][Full Text] [Related]
12. Clinical Value of the Epstein-Barr Virus and p16 Status in Patients with Nasopharyngeal Carcinoma: A Single-Centre Study in Japan.
Saito Y; Ushiku T; Omura G; Yasuhara K; Yoshida M; Takahashi W; Ando M; Fukayama M; Yamasoba T
ORL J Otorhinolaryngol Relat Spec; 2016; 78(6):334-343. PubMed ID: 28171876
[TBL] [Abstract][Full Text] [Related]
13. Nasopharyngeal undifferentiated carcinoma with sarcomatoid features: Pitfalls in the immunohistochemistry.
Lee M; Son HJ; Kim NY; Kim SJ; Yu IK
Malays J Pathol; 2019 Aug; 41(2):201-206. PubMed ID: 31427557
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma: A Brief Review.
Xue F; He X
Methods Mol Biol; 2020; 2204():99-107. PubMed ID: 32710318
[TBL] [Abstract][Full Text] [Related]
15. Retrospective analysis of oncogenic human papilloma virus and Epstein-Barr virus prevalence in Turkish nasopharyngeal cancer patients.
Tatlı Doğan H; Kılıçarslan A; Doğan M; Süngü N; Güler Tezel G; Güler G
Pathol Res Pract; 2016 Nov; 212(11):1021-1026. PubMed ID: 27640103
[TBL] [Abstract][Full Text] [Related]
16. Detection of methylation status of Epstein-Barr virus DNA C promoter in the diagnosis of nasopharyngeal carcinoma.
Zheng XH; Wang RZ; Li XZ; Zhou T; Zhang JB; Zhang PF; Lu LX; Jia WH
Cancer Sci; 2020 Feb; 111(2):592-600. PubMed ID: 31834989
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study.
Guo J; Cui Z; Zheng Y; Li X; Chen Y
Pathol Oncol Res; 2020 Oct; 26(4):2185-2190. PubMed ID: 32222897
[TBL] [Abstract][Full Text] [Related]
18. Non-Keratinizing Nasopharyngeal Carcinoma with Adenomatous Differentiation.
Petersson F
Head Neck Pathol; 2020 Mar; 14(1):195-198. PubMed ID: 30523510
[TBL] [Abstract][Full Text] [Related]
19. Differences in cancer gene copy number alterations between Epstein-Barr virus-positive and Epstein-Barr virus-negative nasopharyngeal carcinoma.
Ooft ML; van Ipenburg J; van de Loo RJM; de Jong R; Moelans CB; de Bree R; de Herdt MJ; Koljenović S; Baatenburg de Jong R; Hardillo J; Willems SM
Head Neck; 2018 Sep; 40(9):1986-1998. PubMed ID: 29927011
[TBL] [Abstract][Full Text] [Related]
20. A Unique Case of Primary EBV-Positive, HPV-Negative Nasopharyngeal Carcinoma Located in the Tonsil.
Nguyen S; Kong T; Berthelet E; Ng T; Prisman E
Head Neck Pathol; 2021 Sep; 15(3):1017-1022. PubMed ID: 33089456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
